Graig Suvannavejh analyst MIZUHO

Currently out of the existing stock ratings of Graig Suvannavejh, 123 are a BUY (65.43%), 58 are a HOLD (30.85%), 7 are a SELL (3.72%).

Graig Suvannavejh

Work Performance Price Targets & Ratings Chart

Analyst Graig Suvannavejh, currently employed at MIZUHO, carries an average stock price target met ratio of 61.28% that have a potential upside of 34.67% achieved within 113 days.

Graig Suvannavejh’s has documented 386 price targets and ratings displayed on 37 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on AXSM, Axsome Therapeutics at 27-Mar-2025.

Wall Street Analyst Graig Suvannavejh

Analyst best performing recommendations are on EYPT (EYEPOINT PHARMACEUTICALS).
The best stock recommendation documented was for EYPT (EYEPOINT PHARMACEUTICALS) at 11/2/2023. The price target of $20 was fulfilled within 35 days with a profit of $12.71 (174.35%) receiving and performance score of 49.81.

Average potential price target upside

ALEC Alector ARQT Arcutis Biotherapeutics  BTAI BioXcel Therapeutics CERE Cerevel Therapeutics Holdings CYTK Cytokinetics FLXN Flexion Therapeutics HALO Halozyme Therapeutics HRMY Harmony Biosciences Holdings INSM Insmed ITCI Intracellular Th JAZZ Jazz Pharmaceuticals PLC KOD Kodiak Sciences ORTX Orchard Therapeutics PLC TGTX TG Therapeutics ATHA Athira Pharma  GMTX Gemini Therapeutics MOR MorphoSys AG ADR RYTM Rhythm Pharmaceuticals XEC Cimarex Energy Co AXSM Axsome Therapeutics RAIN Rain Therapeutics ADVM Adverum Biotechnologies AMLX Amylyx Pharmaceuticals HZNP Horizon Pharma PLC IMCR Immunocore Holdings Ltd IMTX Immatics NV MNTA Momenta Pharmaceuticals PTLA Portola Pharmaceuticals TCDA Tricida AUTL Autolus Therapeutics Ltd EYPT Eyepoint Pharmaceuticals KRTX Karuna Therapeutics TERN Terns Pharmaceuticals VIGL Vigil Neuroscience APLS Apellis Pharmaceuticals CRVS Corvus Pharmaceuticals VALN Valneva SE ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$7

$5.98 (586.27%)

1 months 10 days ago
(27-Feb-2025)

0/5 (0%)

$5.34 (321.69%)

Hold

$4

$2.98 (292.16%)

$15

3 months 21 days ago
(16-Dec-2024)

1/4 (25%)

$2.02 (102.02%)

128

Sell

$3

$1.98 (194.12%)

$10

4 months 11 days ago
(26-Nov-2024)

1/6 (16.67%)

$0.43 (16.73%)

332

Buy

$5

$3.98 (390.20%)

$16

4 months 11 days ago
(26-Nov-2024)

1/3 (33.33%)

$2.43 (94.55%)

70

Buy

4 months 11 days ago
(26-Nov-2024)

0/1 (0%)

$6.12 (88.95%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Graig Suvannavejh is most bullish on?

Potential upside of $117.14 has been obtained for AXSM (AXSOME THERAPEUTICS)

Which stock is Graig Suvannavejh is most reserved on?

Potential downside of -$0 has been obtained for CRVS (CORVUS PHARMACEUTICALS)

What Year was the first public recommendation made by Graig Suvannavejh?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?